Paul Tulkens is a member of the Louvain Drug Research institute and Emeritus Professor at the Université catholique de Louvain (UCL) in Brussels where his research focuses on cellular biology and toxicology, antibiotic pharmacodynamics and cellular pharmacokinetics and, new antibiotic discovery and development.
As Professor of Pharmacology and Pharmacotherapy, Paul has also taught drug discovery and development and, rational therapeutic choices at UCL. He has also been a lecturer in human biochemistry and biochemical pathology at the Université de Mons-Hainaut. He held both positions until 2010.
Before that, Paul had been Fellow, Research Associate and Senior Research Associate of the Belgian Fonds National de la Recherche Scientifique. He also founded and directed the Unit of Cellular and Molecular Pharmacology at the Faculty of Medicine, UCL.
Paul participates as an expert in national and European research programmes on antibiotics, novel and revived, and their monitoring.
He was a member of the Scientific Advisory Group for Antibiotics and Infectious Diseases at the European Medicines Agency and a member of the governance body of DRIVE-AB (Driving reinvestment in R&D for antibiotics and advocating their responsible use).
Paul was also a member of the Belgian Antibiotic Policy Coordination Committee and is an editor and frequent reviewer for several scientific journals dealing with antibiotics and chemotherapy.
Paul has authored about 300 publications in peer-reviewed journals and several book chapters. He has been a presenter at many International meetings, professional conferences and general public events.
Paul graduated as a medical doctor in 1969 and was Research Fellow at the Rockefeller University in New York in 1970. He has obtained his PhD in 1979 at UCL.